Can the Growth/Differentiation Factor-15 Be a Surrogate Target in Chronic Heart Failure Biomarker-Guided Therapy?
Heart failure (HF) biomarker-guided therapy is a promising method, which directs to the improvement of clinical status, attenuation of admission/readmission to the hospital and reduction in mortality rate. Many biological markers, like inflammatory cytokines, are under consideration as a surrogate t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Third Party Medicine International Publishing Group Co. Limited
2017-03-01
|
| Series: | Journal of International Translational Medicine |
| Subjects: | |
| Online Access: | http://www.jitm.hk/EN/abstract/abstract238.shtml |